Cold air keeps croup at bay, and now a study proves itCanadian docs often suggest parents take kids out into the cold. Obesity drug Wegovy cut risk of serious heart problems by 20%, study findsThe findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them. Much ado in the world of Lyme vaccine development Three different approaches in the pipeline. Face mask use reduces SARS-CoV-2 transmission in community settings Use of face masks in the community will be an important component of an effective response to any future respiratory threats. Polypharmacy rising among seniors with heart failure Quebecers aged 65 and over with heart failure are taking more and more different pharmacological treatments, according to a new study Connecting the dots between distraction and neurodegenerative diseases Researchers at Laval University are studying our propensity for distraction in a bid to find ways to slow the progression of certain diseases. U.S. FDA approves new version of diabetes drug Mounjaro for weight loss Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. ChatGPT: an ally in dealing with vaccine hesitancy AI chatbot scores in answering the 50 most frequently asked questions about COVID-19 vaccinations. What was the impact of COVID-19 on front-line pharmacist roles? Dr. Yazid Al Hamarneh and his research team took a unique approach to determine how the recent pandemic influenced pharmacists’ roles and professional identity. Vaccine paves the way for new treatments for allergies A Franco-Quebec company is currently testing a vaccine that could treat human cat allergy and other common allergies in the future. First Previous 72 73 74 75 76 Next Last
